Adverse events associated with the use of Lazanda during the titration phase may include, but are not limited to, the following:
nausea
vomiting
dizziness
Adverse events associated with the use of Lazanda during the maintenance phase may include, but are not limited to, the following:vomiting
nausea
pyrexia
constipation
